Aydin, A. M. Et Al. 2020. Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.. World journal of urology , vol.38, no.10 , 2537-2545.

Aydin, A. M., Baydar, D. E., Hazir, B., Babaoglu, B., & Bilen, C. Y., (2020). Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.. World journal of urology , vol.38, no.10, 2537-2545.

Aydin, Ahmet Et Al. "Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.," World journal of urology , vol.38, no.10, 2537-2545, 2020

Aydin, Ahmet M. Et Al. "Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.." World journal of urology , vol.38, no.10, pp.2537-2545, 2020

Aydin, A. M. Et Al. (2020) . "Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.." World journal of urology , vol.38, no.10, pp.2537-2545.

@article{article, author={Ahmet Murat Aydin Et Al. }, title={Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.}, journal={World journal of urology}, year=2020, pages={2537-2545} }